Incidental primary breast cancer detected on PET–CT
The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify p...
Gespeichert in:
| Veröffentlicht in: | Breast cancer research and treatment 2015-06, Vol.151 (2), p.261-268 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 268 |
|---|---|
| container_issue | 2 |
| container_start_page | 261 |
| container_title | Breast cancer research and treatment |
| container_volume | 151 |
| creator | Benveniste, A. P. Marom, E. M. Benveniste, M. F. Mawlawi, O. Fox, P. S. Yang, Wei |
| description | The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify patients with non-mammary malignancies who had undergone staging with FDG PET–CT at a single institution between September 2005 and September 2011 and with the word “breast” reported in the PET–CT dictation. Additional breast imaging studies, clinical data, and the final histopathology of the breast lesions were correlated with the PET–CT images. Of 1951 patients who underwent PET/CT, 440 incidental breast lesions were identified in 438 patients. Of these 440 lesions, 195 (45 %) were benign, 160 (37 %) malignant, and 85 (19 %) missing data. A total of 25 PBCs were diagnosed; with a median size of 1.8 cm (range 0.8–10.7 cm); and a median SUV
max
of 4.4 (range 1.7–17.6). There were 19 invasive ductal cancers, 1 invasive lobular cancer, 2 papillary cancers, 1 tubular cancer, 1 sarcomatoid cancer, and 1 ductal carcinoma in situ. Eight patients had regional nodal disease. Mammography revealed the PBC in 19 of 23 tumors (83 %), sonography in 22 of 23 (96 %). Six percent (25 of 440) of incidental breast lesions identified on FDG PET–CT represent PBCs; more than half were at an early stage and potentially curable. |
| doi_str_mv | 10.1007/s10549-015-3402-7 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1681262710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A435334949</galeid><sourcerecordid>A435334949</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-86e870538ec5ed47600f09c5cef48ff92ab4f50a3654527a047f2405ae6e574d3</originalsourceid><addsrcrecordid>eNp1kU9rFDEYh4NY7Fr9AF5kQBAvU99k8mdyLEurhUJ7WM8hm3nTTplNapI59OZ38Bv6SZplt9qKkkMgeX4_8uYh5B2FYwqgPmcKgusWqGg7DqxVL8iCCtW1ilH1kiyAStXKHuQheZ3zLQBoBfoVOWRCM62kWBBxHtw4YCh2au7SuLHpvlkntLk0zgaHqRmwoCs4NDE0V6erXz9-LldvyIG3U8a3-_2IfDs7XS2_theXX86XJxetExxK20vsFYiuRydw4EoCeNBOOPS8914zu-ZegO2k4IIpC1x5xkFYlCgUH7oj8mnXe5fi9xlzMZsxO5wmGzDO2VDZUyaZolDRD3-ht3FOob5uS4GmPe_lH-raTmjG4GNJ1m1LzQnvRNdxzXWljv9B1TXgZnQxoB_r-bPAxyeBG7RTuclxmssYQ34O0h3oUsw5oTf7TzcUzNap2Tk11anZOjWqZt7vJ5vXGxx-Jx4lVoDtgFyvwjWmJ6P_t_UB7AmnnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680918486</pqid></control><display><type>article</type><title>Incidental primary breast cancer detected on PET–CT</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Benveniste, A. P. ; Marom, E. M. ; Benveniste, M. F. ; Mawlawi, O. ; Fox, P. S. ; Yang, Wei</creator><creatorcontrib>Benveniste, A. P. ; Marom, E. M. ; Benveniste, M. F. ; Mawlawi, O. ; Fox, P. S. ; Yang, Wei</creatorcontrib><description>The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify patients with non-mammary malignancies who had undergone staging with FDG PET–CT at a single institution between September 2005 and September 2011 and with the word “breast” reported in the PET–CT dictation. Additional breast imaging studies, clinical data, and the final histopathology of the breast lesions were correlated with the PET–CT images. Of 1951 patients who underwent PET/CT, 440 incidental breast lesions were identified in 438 patients. Of these 440 lesions, 195 (45 %) were benign, 160 (37 %) malignant, and 85 (19 %) missing data. A total of 25 PBCs were diagnosed; with a median size of 1.8 cm (range 0.8–10.7 cm); and a median SUV
max
of 4.4 (range 1.7–17.6). There were 19 invasive ductal cancers, 1 invasive lobular cancer, 2 papillary cancers, 1 tubular cancer, 1 sarcomatoid cancer, and 1 ductal carcinoma in situ. Eight patients had regional nodal disease. Mammography revealed the PBC in 19 of 23 tumors (83 %), sonography in 22 of 23 (96 %). Six percent (25 of 440) of incidental breast lesions identified on FDG PET–CT represent PBCs; more than half were at an early stage and potentially curable.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-015-3402-7</identifier><identifier>PMID: 25929765</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biopsy ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - pathology ; Cancer diagnosis ; Cancer research ; Cancer therapies ; CAT scans ; Female ; Fluorodeoxyglucose F18 ; Humans ; Image Interpretation, Computer-Assisted ; Incidental Findings ; Mammography ; Medicine ; Medicine & Public Health ; Multimodal Imaging - methods ; Oncology ; Positron emission tomography ; Review ; Tomography ; Tomography, X-Ray Computed ; Tumor Burden ; Ultrasonic imaging</subject><ispartof>Breast cancer research and treatment, 2015-06, Vol.151 (2), p.261-268</ispartof><rights>Springer Science+Business Media New York 2015</rights><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-86e870538ec5ed47600f09c5cef48ff92ab4f50a3654527a047f2405ae6e574d3</citedby><cites>FETCH-LOGICAL-c540t-86e870538ec5ed47600f09c5cef48ff92ab4f50a3654527a047f2405ae6e574d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-015-3402-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-015-3402-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25929765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Benveniste, A. P.</creatorcontrib><creatorcontrib>Marom, E. M.</creatorcontrib><creatorcontrib>Benveniste, M. F.</creatorcontrib><creatorcontrib>Mawlawi, O.</creatorcontrib><creatorcontrib>Fox, P. S.</creatorcontrib><creatorcontrib>Yang, Wei</creatorcontrib><title>Incidental primary breast cancer detected on PET–CT</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify patients with non-mammary malignancies who had undergone staging with FDG PET–CT at a single institution between September 2005 and September 2011 and with the word “breast” reported in the PET–CT dictation. Additional breast imaging studies, clinical data, and the final histopathology of the breast lesions were correlated with the PET–CT images. Of 1951 patients who underwent PET/CT, 440 incidental breast lesions were identified in 438 patients. Of these 440 lesions, 195 (45 %) were benign, 160 (37 %) malignant, and 85 (19 %) missing data. A total of 25 PBCs were diagnosed; with a median size of 1.8 cm (range 0.8–10.7 cm); and a median SUV
max
of 4.4 (range 1.7–17.6). There were 19 invasive ductal cancers, 1 invasive lobular cancer, 2 papillary cancers, 1 tubular cancer, 1 sarcomatoid cancer, and 1 ductal carcinoma in situ. Eight patients had regional nodal disease. Mammography revealed the PBC in 19 of 23 tumors (83 %), sonography in 22 of 23 (96 %). Six percent (25 of 440) of incidental breast lesions identified on FDG PET–CT represent PBCs; more than half were at an early stage and potentially curable.</description><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer diagnosis</subject><subject>Cancer research</subject><subject>Cancer therapies</subject><subject>CAT scans</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Image Interpretation, Computer-Assisted</subject><subject>Incidental Findings</subject><subject>Mammography</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multimodal Imaging - methods</subject><subject>Oncology</subject><subject>Positron emission tomography</subject><subject>Review</subject><subject>Tomography</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumor Burden</subject><subject>Ultrasonic imaging</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kU9rFDEYh4NY7Fr9AF5kQBAvU99k8mdyLEurhUJ7WM8hm3nTTplNapI59OZ38Bv6SZplt9qKkkMgeX4_8uYh5B2FYwqgPmcKgusWqGg7DqxVL8iCCtW1ilH1kiyAStXKHuQheZ3zLQBoBfoVOWRCM62kWBBxHtw4YCh2au7SuLHpvlkntLk0zgaHqRmwoCs4NDE0V6erXz9-LldvyIG3U8a3-_2IfDs7XS2_theXX86XJxetExxK20vsFYiuRydw4EoCeNBOOPS8914zu-ZegO2k4IIpC1x5xkFYlCgUH7oj8mnXe5fi9xlzMZsxO5wmGzDO2VDZUyaZolDRD3-ht3FOob5uS4GmPe_lH-raTmjG4GNJ1m1LzQnvRNdxzXWljv9B1TXgZnQxoB_r-bPAxyeBG7RTuclxmssYQ34O0h3oUsw5oTf7TzcUzNap2Tk11anZOjWqZt7vJ5vXGxx-Jx4lVoDtgFyvwjWmJ6P_t_UB7AmnnQ</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Benveniste, A. P.</creator><creator>Marom, E. M.</creator><creator>Benveniste, M. F.</creator><creator>Mawlawi, O.</creator><creator>Fox, P. S.</creator><creator>Yang, Wei</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150601</creationdate><title>Incidental primary breast cancer detected on PET–CT</title><author>Benveniste, A. P. ; Marom, E. M. ; Benveniste, M. F. ; Mawlawi, O. ; Fox, P. S. ; Yang, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-86e870538ec5ed47600f09c5cef48ff92ab4f50a3654527a047f2405ae6e574d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer diagnosis</topic><topic>Cancer research</topic><topic>Cancer therapies</topic><topic>CAT scans</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Image Interpretation, Computer-Assisted</topic><topic>Incidental Findings</topic><topic>Mammography</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multimodal Imaging - methods</topic><topic>Oncology</topic><topic>Positron emission tomography</topic><topic>Review</topic><topic>Tomography</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumor Burden</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Benveniste, A. P.</creatorcontrib><creatorcontrib>Marom, E. M.</creatorcontrib><creatorcontrib>Benveniste, M. F.</creatorcontrib><creatorcontrib>Mawlawi, O.</creatorcontrib><creatorcontrib>Fox, P. S.</creatorcontrib><creatorcontrib>Yang, Wei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Benveniste, A. P.</au><au>Marom, E. M.</au><au>Benveniste, M. F.</au><au>Mawlawi, O.</au><au>Fox, P. S.</au><au>Yang, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidental primary breast cancer detected on PET–CT</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>151</volume><issue>2</issue><spage>261</spage><epage>268</epage><pages>261-268</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify patients with non-mammary malignancies who had undergone staging with FDG PET–CT at a single institution between September 2005 and September 2011 and with the word “breast” reported in the PET–CT dictation. Additional breast imaging studies, clinical data, and the final histopathology of the breast lesions were correlated with the PET–CT images. Of 1951 patients who underwent PET/CT, 440 incidental breast lesions were identified in 438 patients. Of these 440 lesions, 195 (45 %) were benign, 160 (37 %) malignant, and 85 (19 %) missing data. A total of 25 PBCs were diagnosed; with a median size of 1.8 cm (range 0.8–10.7 cm); and a median SUV
max
of 4.4 (range 1.7–17.6). There were 19 invasive ductal cancers, 1 invasive lobular cancer, 2 papillary cancers, 1 tubular cancer, 1 sarcomatoid cancer, and 1 ductal carcinoma in situ. Eight patients had regional nodal disease. Mammography revealed the PBC in 19 of 23 tumors (83 %), sonography in 22 of 23 (96 %). Six percent (25 of 440) of incidental breast lesions identified on FDG PET–CT represent PBCs; more than half were at an early stage and potentially curable.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25929765</pmid><doi>10.1007/s10549-015-3402-7</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6806 |
| ispartof | Breast cancer research and treatment, 2015-06, Vol.151 (2), p.261-268 |
| issn | 0167-6806 1573-7217 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1681262710 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Biopsy Breast cancer Breast Neoplasms - diagnosis Breast Neoplasms - pathology Cancer diagnosis Cancer research Cancer therapies CAT scans Female Fluorodeoxyglucose F18 Humans Image Interpretation, Computer-Assisted Incidental Findings Mammography Medicine Medicine & Public Health Multimodal Imaging - methods Oncology Positron emission tomography Review Tomography Tomography, X-Ray Computed Tumor Burden Ultrasonic imaging |
| title | Incidental primary breast cancer detected on PET–CT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A19%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidental%20primary%20breast%20cancer%20detected%20on%20PET%E2%80%93CT&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Benveniste,%20A.%20P.&rft.date=2015-06-01&rft.volume=151&rft.issue=2&rft.spage=261&rft.epage=268&rft.pages=261-268&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1007/s10549-015-3402-7&rft_dat=%3Cgale_proqu%3EA435334949%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680918486&rft_id=info:pmid/25929765&rft_galeid=A435334949&rfr_iscdi=true |